| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/24/1997 | WO1997026356A1 PHENYLALANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026354A1 HISTIDYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026353A1 ALANYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026352A1 STAPHYLOCOCCUS AUREUS SERYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026351A1 STAPHYLOCOCCUS AUREUS TYROSYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026350A1 STAPHYLOCOCCUS AUREUS METHIONYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026348A1 ASPARAGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026345A1 GLUTAMYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026341A1 CYSTEINYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026340A1 STAPHYLOCOCCUS AUREUS GLYCYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026338A1 Staphylococcus aureus wcuh29 spoiiie protein |
| 07/24/1997 | WO1997026331A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 07/24/1997 | WO1997026274A1 Leptospiral outer membrane proteins |
| 07/24/1997 | WO1997026273A1 Borrelia burgdorferi outer membrane proteins |
| 07/24/1997 | WO1997026010A1 Anticoagulant agents useful in treatment of thrombosis |
| 07/24/1997 | WO1997026008A1 STREPTOCOCCAL C5a PEPTIDASE VACCINE |
| 07/24/1997 | WO1997026007A1 Mycobacterium antigens and methods for their detection |
| 07/24/1997 | WO1997026006A1 Compositions and methods for administering borrelia burgdorferi antigens |
| 07/24/1997 | WO1997026001A1 Proteins and peptides for contraceptive vaccines and fertility diagnosis |
| 07/24/1997 | WO1997026000A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | WO1997025860A1 Cellular immunogens useful as cancer vaccines |
| 07/24/1997 | WO1997018300A3 Murine model for human carcinoma |
| 07/24/1997 | WO1997007198A3 Dna sequences and secreted proteins encoded thereby |
| 07/24/1997 | CA2243531A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | CA2243526A1 Compositions and methods for administering borrelia burgdorferi antigens |
| 07/24/1997 | CA2242376A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | CA2241952A1 Cellular immunogens useful as cancer vaccines |
| 07/24/1997 | CA2215900A1 Leptospiral outer membrane proteins |
| 07/24/1997 | CA2214840A1 System for the expression of heterologous antigens as fusion proteins |
| 07/23/1997 | EP0785272A1 Prolyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785270A1 Staphylococcus aureus Seryl-tRNA synthetase |
| 07/23/1997 | EP0785269A1 Histidyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785268A1 Staphylococcus aureus methionyl-tRNA synthetase |
| 07/23/1997 | EP0785267A1 Valyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785266A1 Arginyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785262A1 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785261A1 Glutamyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785260A1 Alanyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785259A1 Asparaginyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase |
| 07/23/1997 | EP0785257A1 Cysteinyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785256A1 Staphylococcus aureus glycyl-tRNA synthetase |
| 07/23/1997 | EP0785217A1 Method of immunoassay for human BPGM |
| 07/23/1997 | EP0784688A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 07/23/1997 | EP0784686A1 Herpes simplex virus glycoprotein d variants |
| 07/23/1997 | EP0784685A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 07/23/1997 | EP0784683A1 Tie-2 ligands, methods of making and uses thereof |
| 07/23/1997 | EP0784682A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof |
| 07/23/1997 | EP0784676A1 Neutralization of foof allergens by thioredoxin |
| 07/23/1997 | EP0784672A1 Human inositol monophosphatase h1 |
| 07/23/1997 | EP0784631A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 07/23/1997 | EP0784486A1 Interleukin-12 as an adjuvant for paramyxoviridae vaccines |
| 07/23/1997 | EP0784485A1 Vaccine compositions |
| 07/23/1997 | EP0784483A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/23/1997 | EP0784482A2 Methods for inhibiting antigen specific t cell responses |
| 07/23/1997 | EP0784478A1 Inhibition of endothelin-1 to reduce inflammatory processes |
| 07/23/1997 | EP0784477A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 07/23/1997 | EP0784469A1 Compositions for the delivery of antigens |
| 07/23/1997 | EP0586617B1 Anti-CD3 aglycosylated IgG Antibody |
| 07/23/1997 | EP0474846B1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides |
| 07/23/1997 | EP0474727B1 Her2 extracellular domain |
| 07/23/1997 | EP0451194B1 Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 07/23/1997 | CN1155246A CCK antibodies used to improve feed efficiency |
| 07/22/1997 | US5650504 Nucleic acids encoding eck receptor ligands |
| 07/22/1997 | US5650489 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 07/22/1997 | US5650488 Polypeptide inhibitor of the replication of HSV |
| 07/22/1997 | US5650398 Drug delivery enhancement via modified saponins |
| 07/22/1997 | US5650386 Compositions for oral delivery of active agents |
| 07/22/1997 | US5650324 Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase |
| 07/22/1997 | US5650318 Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus |
| 07/22/1997 | US5650309 Viral vectors |
| 07/22/1997 | US5650300 Method of producing monoclonal antibodies to oncofetal protein |
| 07/22/1997 | US5650299 Cells producing stem cell proliferation factor |
| 07/22/1997 | US5650296 Expression of hepatitis B S and preS2 proteins in Pichia pastoris |
| 07/22/1997 | US5650292 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them |
| 07/22/1997 | US5650155 Tocols as adjuvant in vaccine |
| 07/22/1997 | US5650154 Protective antigens against disease pathogens |
| 07/22/1997 | US5650153 Genetic engineering, viruses and genomic dna |
| 07/22/1997 | US5650152 Vaccines for antitumor agents |
| 07/22/1997 | US5650151 Citrus proteins for use in field detection of citrus blight using immunological techniques |
| 07/22/1997 | US5650135 Non-invasive localization of a light-emitting conjugate in a mammal |
| 07/17/1997 | WO1997025431A1 Compositions and methods for the treatment and diagnosis of cancer |
| 07/17/1997 | WO1997025430A1 Calcium binding proteolipid compositions and methods |
| 07/17/1997 | WO1997025429A1 Helicobacter pylori bacterioferritin |
| 07/17/1997 | WO1997025428A1 Apo-2 ligand |
| 07/17/1997 | WO1997025426A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 07/17/1997 | WO1997025425A1 Wsx receptor and ligands |
| 07/17/1997 | WO1997025415A1 Process for the deactivation of hiv and other viruses |